Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Champions Oncolog (NQ: CSBR ) 4.545 +0.055 (+1.22%) Streaming Delayed Price Updated: 10:43 AM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Champions Oncolog < Previous 1 2 3 Next > Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million March 15, 2022 HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... From Champions Oncology, Inc. Via AccessWire Earnings Scheduled For March 15, 2022 March 15, 2022 Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi... Via Benzinga Earnings Preview For Champions Oncology March 14, 2022 Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts... Via Benzinga Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022 March 11, 2022 HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... From Champions Oncology, Inc. Via AccessWire Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors February 15, 2022 HACKENSACK, NJ / ACCESSWIRE / February 15, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... From Champions Oncology, Inc. Via AccessWire Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates January 20, 2022 HACKENSACK, NJ / ACCESSWIRE / January 20, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... From Champions Oncology, Inc. Via AccessWire Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs January 04, 2022 HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative pharmacology,... From Champions Oncology, Inc. Via AccessWire Looking Into Champions Oncology's Return On Capital Employed December 14, 2021 According to Benzinga Pro, during Q2, Champions Oncology (NASDAQ:CSBR) earned $277.00 thousand, a 261.05% increase from the preceding quarter. Champions Oncology also posted a... Via Benzinga Champions Oncology Reports Record Quarterly Revenue of $11.8 Million December 13, 2021 Reported income from operations of $263,000 HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming... From Champions Oncology, Inc. Via AccessWire Earnings Scheduled For December 13, 2021 December 13, 2021 Companies Reporting Before The Bell • Qudian (NYSE:QD) is projected to report quarterly earnings at $0.18 per share on revenue of $56.15 million. Companies... Via Benzinga Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021 December 06, 2021 HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report... From Champions Oncology, Inc. Via AccessWire Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus October 20, 2021 HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned... From Champions Oncology, Inc. Via AccessWire 12 Health Care Stocks Moving In Thursday's After-Market Session September 16, 2021 Gainers Stealth BioTherapeutics (NASDAQ: Via Benzinga Champions Oncology Reports Record Quarterly Revenue of $11.3 Million September 13, 2021 HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced its... From Champions Oncology, Inc. Via AccessWire Topics Earnings Exposures Financial Earnings Scheduled For September 13, 2021 September 13, 2021 Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third quarter. • NAPCO Security (NASDAQ:NSSC) is estimated... Via Benzinga Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021 September 02, 2021 HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and development will report its... From Champions Oncology, Inc. Via AccessWire Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development July 26, 2021 HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative... From Champions Oncology, Inc. Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence Champions Oncology Reports Quarterly Revenue of $10.6 Million July 22, 2021 Record Annual Revenue of $41 Million HACKENSACK, NJ / ACCESSWIRE / July 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in creating transformative technology solutions to be utilized in drug... From Champions Oncology, Inc. Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021 July 14, 2021 HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative... From Champions Oncology, Inc. Via AccessWire Earnings Scheduled For July 22, 2021 July 22, 2021 Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,... Via Benzinga Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions June 15, 2021 HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI... From Champions Oncology, Inc. Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence 3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More May 30, 2021 Wall Street analysts expect the biotech industry to grow significantly soon, with the biotech stocks Organogenesis (ORGO), BioDelivery Sciences (BDSI) and Champions Oncology (CSBR) gaining more... Via Talk Markets < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.